Grimes & Company’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,160
Closed -$205K 252
2018
Q3
$205K Buy
+2,160
New +$184K 0.02% 232
2016
Q2
Sell
-2,931
Closed -$201K 227
2016
Q1
$201K Sell
2,931
-1,301
-31% -$93.5K 0.03% 186
2015
Q4
$370K Buy
4,232
+886
+26% +$75.9K 0.05% 136
2015
Q3
$271K Sell
3,346
-57,768
-95% -$5.03M 0.03% 152
2015
Q2
$5.43M Sell
61,114
-361
-0.6% -$31.5K 0.77% 36
2015
Q1
$5.33M Buy
61,475
+1,498
+2% +$126K 1.28% 33
2014
Q4
$5.08M Buy
59,977
+1,000
+2% +$78.1K 1.31% 26
2014
Q3
$4.17M Buy
58,977
+1,075
+2% +$76.6K 1.09% 39
2014
Q2
$4.01M Buy
57,902
+577
+1% +$40.6K 1.05% 40
2014
Q1
$4.3M Buy
57,325
+470
+0.8% +$35.2K 1.21% 34
2013
Q4
$3.99M Buy
+56,855
New +$3.71M 1.19% 37

Other funds holding ESRX

Grimes & Company's ESRX Position: Q4 2018 in Review

Grimes & Company sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 2,160 shares — an estimated $205K sold.

Grimes & Company first reported a position in ESRX in Q4 2013 and held it in 11 quarters. The position peaked at $5.43M in Q2 2015. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Grimes & Company reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Grimes & Company sold 2,160 Express Scripts Holding Company shares in Q4 2018, an estimated $205K.
  • Grimes & Company first reported a position in Express Scripts Holding Company in Q4 2013 and held it in 11 quarters.
  • Grimes & Company's Express Scripts Holding Company position peaked at $5.43M in Q2 2015.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Grimes & Company's 13F filing for Q4 2018, filed 1 Feb 2019.